Hubbry Logo
Bypass surgeryBypass surgeryMain
Open search
Bypass surgery
Community hub
Bypass surgery
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Bypass surgery
Bypass surgery
Bypass surgery
View on Wikipedia
from Wikipedia
Bypass surgery
ICD-10-PCS0?1

Bypass surgery refers to a class of surgery involving rerouting a tubular body part.[1]

Types include:

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Bypass surgery

View on Grokipedia
from Grokipedia
Bypass surgery refers to a class of surgical procedures designed to create a around a blocked or narrowed section of a bodily pathway, such as a or segment of the digestive tract, to restore normal flow and function. These procedures are used to treat various conditions, including , , and peripheral . Common types include coronary artery bypass grafting (CABG) for heart disease, gastric bypass for severe , and peripheral vascular bypass for blockages in limbs. Detailed information on each type, including indications, techniques, risks, and outcomes, is covered in the following sections. CABG, the most common form of bypass surgery for cardiovascular conditions, involves using healthy blood vessels from elsewhere in the body to reroute blood flow around blocked , aiming to relieve , improve survival, and enhance quality of life in selected patients. Worldwide, hundreds of thousands of bypass procedures of various types are performed annually, with approximately 160,000 CABG surgeries in the United States as of 2023, though volumes have declined due to advances in alternatives like (PCI).

Overview

Definition and Purpose

Bypass surgery is a surgical procedure that creates an alternative pathway, or , around a blocked, narrowed, or damaged tubular structure in the body to restore normal flow of fluids or substances. This technique typically involves the use of grafts—either autologous tissues harvested from the patient's own body, such as veins or segments of intestine, or synthetic materials—to reroute the pathway and circumvent the diseased segment. The primary purpose of bypass surgery is to reestablish or improve the function of the affected structure by avoiding the obstructed or dysfunctional area, thereby preventing complications such as tissue damage, organ , or metabolic imbalances. In vascular applications, it aims to restore adequate flow to deprived tissues, while in gastrointestinal cases, it alters absorption and to achieve therapeutic goals like . Overall, the procedure enhances physiological processes that have been compromised by , promoting better outcomes without directly repairing the original blockage. Common anatomical targets for bypass surgery include blood vessels, such as arteries and veins (coronary), limbs (peripheral), or other vascular regions, as well as the in procedures like gastric bypass. Less frequently, it targets other ductal systems, such as the bile ducts in biliary bypass surgeries to relieve obstructions. Unlike less invasive interventions such as , which widens narrowed vessels using a without creating a new conduit, bypass surgery physically constructs a detour using grafted material to provide a durable alternative route. Major types include coronary artery bypass grafting for heart disease, gastric bypass for , and peripheral artery bypass for limb ischemia, each tailored to specific clinical needs.

Historical Development

The foundations of bypass surgery were laid in the early through pioneering work in vascular . In 1902, French surgeon , collaborating with American physiologist Charles Guthrie, developed the triangulation technique for suturing blood vessels end-to-end, enabling successful arteriovenous connections without or ; this innovation earned Carrel the Nobel Prize in Physiology or Medicine in 1912. Their experiments on animal models in the 1900s demonstrated the feasibility of vessel grafting, setting the stage for later reconstructive procedures. Gastrointestinal bypass procedures emerged in the late to address peptic complications. In 1885, Austrian surgeon performed the first gastrojejunostomy as a two-stage approach for pyloric obstruction caused by ulcers, bypassing the to restore gastric drainage. This technique evolved through the early 20th century, with refinements in the 1950s incorporating and to reduce acid secretion and prevent recurrence, though resectional therapies like remained influential for severe cases. Peripheral vascular bypass surgery advanced in the mid-20th century to treat lower limb ischemia. In 1948, French surgeon Jean Kunlin introduced the first using a reversed autologous saphenous graft, successfully restoring blood flow in a with critical limb-threatening ischemia and establishing autografts as the gold standard for small-diameter vessel reconstruction. This approach gained widespread adoption in the , improving patency rates over synthetic alternatives. Coronary artery bypass grafting (CABG) originated in the 1960s amid efforts to revascularize ischemic myocardium. Soviet surgeon Vasili Kolessov performed the first internal mammary artery-to-coronary artery in 1960 on a beating heart, reporting long-term patency in subsequent cases. In 1953, American surgeon achieved a milestone with the first successful use of a heart-lung machine for extracorporeal circulation during open-heart , closing an and enabling intracardiac procedures under . Argentine surgeon refined CABG at the , performing the first saphenous vein graft interposition to the in May 1967, which demonstrated immediate symptom relief and patency. Bariatric bypass surgery developed in the as a treatment for morbid . In 1967, American surgeons Edward Mason and Chikashi Ito introduced the Roux-en-Y gastric bypass, creating a small gastric pouch and rerouting the to limit intake and absorption, inspired by observed post-gastrectomy for ulcers. This procedure evolved in the 1990s with minimally invasive techniques; in 1994, Alan Wittgrove performed the first laparoscopic Roux-en-Y gastric bypass, reducing recovery time and complications compared to open surgery. Key innovations in the late 20th and early 21st centuries enhanced bypass safety and efficacy. Off-pump CABG techniques, avoiding cardiopulmonary bypass, gained prominence in the 1990s to minimize systemic inflammation and neurological risks, with early adopters like Federico Benetti reporting successful multivessel revascularizations on the beating heart. Robotic-assisted totally endoscopic coronary artery bypass (TECAB) emerged in the late 1990s and 2000s; the first procedure was performed in 1998 by Alain Loulmet using the da Vinci system, followed by off-pump TECAB in 2000, enabling precise anastomoses through small incisions. Recent developments up to 2025 include bioengineered grafts, such as acellular tissue-engineered vessels from Humacyte, which demonstrated 100% patency in nonhuman primate CABG models over six months in 2024 preclinical trials, offering promise for off-the-shelf alternatives to autologous veins with reduced failure rates.

General Surgical Principles

Preoperative assessment in bypass surgery involves comprehensive to identify and vascular blockages or anatomical targets, such as coronary angiography for arterial occlusions or computed tomography (CT) scans for detailed visualization of vessel anatomy and potential graft sites. This evaluation is typically multidisciplinary, incorporating input from cardiologists to assess cardiac function, anesthesiologists to optimize perioperative risk, and surgeons to plan procedural feasibility, ensuring patient stability and procedural safety. Graft materials for bypass procedures are selected based on factors like long-term durability, biocompatibility, and availability, with autologous options preferred for their reduced risk of rejection and . Common autologous grafts include the saphenous vein, harvested from the leg, and the internal mammary artery, valued for its endothelial integrity and patency rates exceeding 90% at 10 years in arterial applications. Allogeneic grafts from donors or synthetic alternatives like Dacron () and expanded (PTFE) are used when autologous tissue is insufficient, though synthetics carry higher occlusion risks due to compliance mismatch with native vessels. Selection prioritizes materials that mimic native vessel mechanics to minimize intimal hyperplasia and promote endothelialization. Anastomosis techniques form the core of graft integration, employing precise suturing to connect the graft to target vessels while preserving lumen patency and minimizing turbulence. End-to-end joins graft ends directly for straight conduits, whereas end-to-side configurations allow branching to native vessels, both performed with fine monofilament sutures such as 6-0 to 8-0 to ensure watertight seals under . Surgical via loupes (2-5x) or operating microscopes enhances precision, reducing error in vessel handling and suture placement, particularly for small-caliber anastomoses under 3 mm. Intraoperative monitoring focuses on maintaining hemodynamic stability through continuous assessment of , , and , often using invasive lines and . Anticoagulation with unfractionated (typically 300 U/kg) is standard to prevent clot formation during vessel manipulation, with activated clotting time (ACT) targeted above 400 seconds for efficacy. In procedures requiring temporary flow diversion, intracoronary shunts or machines are employed to sustain distal and organ viability, innovations like the latter enabling complex multivessel interventions since the mid-20th century. Postoperative management emphasizes anticoagulation therapy, such as or , to support graft patency and prevent thromboembolic events, tailored to individual risk profiles. Wound care protocols include sterile dressings, infection surveillance, and pain control to facilitate healing, while is routinely used to confirm graft flow and detect early stenoses through measurements. Ethical considerations in bypass surgery center on , where patients must be fully apprised of procedural risks, benefits, and the potential irreversibility of anatomical changes, such as gastric reservoir reduction in bariatric variants, to uphold and mitigate regret. This process involves clear communication of long-term implications, ensuring voluntary agreement without coercion, as guided by professional standards in surgical ethics.

Coronary Artery Bypass Grafting (CABG)

Indications and Patient Selection

Coronary artery bypass grafting (CABG) is indicated for patients with severe coronary artery disease (CAD) where medical therapy or percutaneous coronary intervention (PCI) is insufficient. According to the 2011 ACCF/AHA guidelines (Class I recommendations), CABG is recommended for left main coronary artery disease with greater than 50% stenosis, three-vessel disease with greater than 70% stenosis in major vessels (with or without proximal left anterior descending [LAD] involvement), and two-vessel disease involving the proximal LAD plus another major artery. It is also indicated for significant stenosis greater than 70% with persistent angina despite optimal medical therapy, or in survivors of sudden cardiac death due to ischemia-related ventricular arrhythmias. Patient selection considers factors such as symptom severity (e.g., or post-myocardial infarction ischemia), left ventricular function, and comorbidities like or , which may favor CABG over PCI for better long-term outcomes in complex disease. Contraindications include patient refusal, unsuitable coronary anatomy (e.g., no distal targets), or absence of viable myocardium on imaging. Approximately 400,000 CABG procedures are performed annually in the United States.

Surgical Procedure

CABG involves harvesting healthy blood vessels to create detours around blocked , restoring blood flow to the heart muscle. The procedure is typically performed under general anesthesia and lasts 3 to 6 hours. A provides access to the heart, though minimally invasive approaches use smaller incisions or robotic assistance in select cases. Common grafts include the left internal mammary artery (), which is anastomosed to the LAD, and saphenous veins from the , connected end-to-side to the proximally and beyond the blockage distally. Arterial grafts like the offer superior long-term patency. Two main techniques exist: on-pump CABG, using a heart-lung machine to stop the heart and maintain circulation; and off-pump (beating-heart) CABG, which avoids to potentially reduce inflammation and bleeding risks. The surgical team includes a cardiothoracic , anesthesiologist, , and nurses.

Risks and Complications

CABG carries risks influenced by patient factors such as age, , and emergency status. Perioperative mortality is 1-2%, increasing with comorbidities. Common complications include (20-50% within 5 days postoperatively, often managed with beta-blockers), (1-2%, associated with age and prior events), renal dysfunction (2-3%, with 1% requiring dialysis; off-pump may lower this), and sternal wound infection (about 1%, higher in obese or diabetic patients). Graft failure affects up to 25% of saphenous grafts within 30 days, though grafts maintain over 90% patency at 10 years. Other risks include bleeding, infection, irregular heart rhythms, , and memory issues (often temporary). Higher-risk groups include those with or advanced age.

Outcomes and Recovery

CABG provides symptom relief (e.g., reduced ), improved , and survival benefits over medical therapy or PCI in patients with multivessel disease or left main involvement. Long-term patency and reduced heart attack risk contribute to enhanced survival, particularly in diabetics with complex CAD. Postoperatively, patients spend 1-2 days in the for monitoring, followed by a total stay of up to one week. Recovery involves 6-12 weeks to resume normal activities, with driving and work typically possible after 4-6 weeks pending medical clearance. programs, starting in the , emphasize exercise, education, and lifestyle changes (e.g., , diet, medications like antiplatelets and statins) to optimize outcomes and prevent progression.

Gastric Bypass Surgery

Indications and Patient Selection

Gastric bypass surgery, most commonly the Roux-en-Y gastric bypass (RYGB), is a bariatric procedure indicated for adults with severe obesity who have not achieved adequate weight loss through diet, exercise, and behavioral interventions. It is typically recommended for individuals with a (BMI) of 40 kg/m² or higher, or a BMI of 35 kg/m² or higher in the presence of obesity-related comorbidities such as , , , , or . Patient selection involves a comprehensive multidisciplinary , including assessment to rule out contraindications (e.g., uncontrolled endocrine disorders, certain cancers), psychological screening to ensure readiness for changes, and nutritional counseling to confirm commitment to long-term follow-up. According to the American Society for Metabolic and Bariatric Surgery (ASMBS) guidelines, surgery may also be considered for BMI greater than 30 kg/m² with poorly controlled . Adolescents and older adults may qualify under specific criteria, but generally, candidates are aged 18-65 years with a of at least 5 years. Contraindications include active , severe untreated psychiatric illness, or inability to comprehend postoperative requirements.

Surgical Procedure

Roux-en-Y gastric bypass is usually performed laparoscopically under general , lasting 2-4 hours. The divides the to create a small pouch (typically 15-30 mL) from the upper portion, which restricts intake. The is then divided about 30-50 cm distal to the to form the biliopancreatic limb, and a limb (75-150 cm long) is anastomosed to the gastric pouch in a Y-configuration, bypassing the and proximal to reduce nutrient absorption. The biliopancreatic limb is reconnected to the common channel downstream. Stapling devices secure the divisions, and anastomoses use sutures or staples. In select cases, an open approach via may be necessary for anatomical challenges or prior surgeries. Intraoperative or leak testing ensures integrity. Minimally invasive robotic assistance can be used to enhance precision.

Risks and Complications

carries perioperative risks, with overall mortality rates of 0.2-0.5% and major complication rates of 5-10%. Short-term complications include anastomotic leaks (1-2%), bleeding (2-3%), infection (1-5%), blood clots ( thrombosis or , 0.5-1%), and (2%). , causing , , and flushing after high-sugar meals, affects 20-50% of patients early on. Long-term risks involve nutritional deficiencies due to , such as iron (up to 50%), (30-70%), , and calcium, requiring lifelong supplementation and monitoring. Other issues include marginal ulcers (5-15%), internal hernias (2-10%), gallstones (10-20%), gastroesophageal reflux worsening, and weight regain (20-30% of patients after 5-10 years). Strictures or fistulas may necessitate revision surgery in 5-10% of cases. Risks are higher in patients with comorbidities like or prior .

Outcomes and Recovery

Following gastric bypass surgery, patients typically achieve substantial , with an average of 60-80% excess body weight lost within the first 1-2 years, though this often plateaus at 50-70% long-term maintenance with ongoing adherence to dietary and lifestyle recommendations. This weight reduction is attributed to the procedure's malabsorptive and restrictive effects, which limit caloric intake and nutrient absorption, leading to sustained outcomes in most cases when supported by multidisciplinary care. Resolution of obesity-related comorbidities is a key benefit, with achieving remission in 70-80% of patients, often within months of surgery due to improved insulin sensitivity and reduced . improves or resolves in 60-70% of cases, reflecting decreased through and metabolic changes. (OSA) resolves in approximately 85% of patients, alleviating symptoms like daytime fatigue and improving respiratory function. Recovery begins in the hospital, where patients typically stay 2-3 days postoperatively, transitioning to clear liquids within hours of surgery to assess tolerance and prevent complications. Diet progresses gradually: from clear liquids for the first day or two, to full liquids and pureed foods over the initial 1-2 weeks, soft foods by 4 weeks, and solid foods by 6-8 weeks, emphasizing high-protein intake and portion control to support healing and . Full , including exercise, is generally resumed 4-6 weeks after surgery, once cleared by the surgical team, to promote mobility and metabolic health. Long-term follow-up is essential, involving annual visits to monitor weight, nutritional status, and comorbidities, alongside behavioral to enhance adherence to dietary and exercise regimens. Compliance with lifelong and supplementation, along with balanced , sustains these outcomes and prevents deficiencies that could otherwise impact recovery. improves markedly, with enhanced mobility, reduced joint pain, and better reported by most patients, contributing to a 5-year survival benefit including approximately 30% reduced cardiovascular mortality as demonstrated in the Swedish Obese Subjects (SOS) study. In cases of weight regain, which affects outcomes in some patients, surgical revisions are performed in 10-20% of individuals to restore restriction or address anatomical issues, often yielding additional when combined with renewed behavioral support.

Peripheral Vascular Bypass

Indications and Patient Selection

Peripheral vascular bypass surgery is primarily indicated for patients with critical limb-threatening ischemia (CLTI), characterized by rest pain, non-healing ulcers, or due to advanced (PAD), where is essential to prevent major . This condition typically corresponds to Rutherford classification categories III-VI, encompassing severe , ischemic rest pain (category IV), minor tissue loss such as non-healing ulcers (category V), and major tissue loss including (category VI). For less severe (Rutherford categories I-III), bypass is considered only if symptoms are lifestyle-limiting and unresponsive to conservative measures and endovascular interventions, particularly in proximal disease segments. The surgery targets occlusive disease in key anatomic sites, including aortoiliac, femoropopliteal, and infrapopliteal (tibial) arteries, with multilevel involvement common in CLTI patients. Patient selection emphasizes hemodynamic severity, assessed by an ankle-brachial index (ABI) less than 0.4, indicating profound ischemia and poor perfusion. Preoperative evaluation includes duplex ultrasound to confirm suitable autologous vein conduit availability, such as greater saphenous vein, which is preferred for long-term patency in infrainguinal bypass. The Wound, Ischemia, and foot Infection (WIfI) classification system, endorsed by the Society for Vascular Surgery (SVS), further stratifies risk by integrating clinical wound grade, ischemia severity (e.g., ABI or toe pressure), and infection to guide urgency and prognosis, with higher stages (3-4) warranting prompt revascularization. Comorbidities significantly influence selection, as diabetes mellitus is present in approximately 50% of CLTI cases and is associated with more distal disease and higher risk, necessitating tailored bypass targets like femorotibial grafts. A markedly elevates graft failure risk, with continued use post-surgery conferring a threefold increase in occlusion rates compared to cessation. According to SVS Global Vascular Guidelines, is favored over primary in average-risk patients with viable limbs (periprocedural mortality <5%, >50% 2-year ) and adequate target arterial path anatomy, prioritizing limb salvage through in-line flow restoration. Contraindications include absence of suitable autologous vein with reliance on prosthetic grafts in high-risk settings, inadequate distal runoff vessels (e.g., Global Limb Anatomic Staging System stage III), or limited of less than 2 years, where procedural risks outweigh benefits and or may be more appropriate.

Surgical Procedure

Peripheral surgery involves creating a conduit to reroute blood flow around occluded or stenotic arteries in the lower extremities, typically using an autogenous vein or prosthetic graft. The standard approach for femoral-popliteal (fem-pop) bypass utilizes an infringuinal incision to access the common proximally and the distally, allowing for direct exposure of the target vessels. For more complex cases involving multiple lesions or calcified vessels, hybrid endovascular techniques may be incorporated, combining open surgery with catheter-based interventions to facilitate graft placement. Graft selection prioritizes the , harvested from the ipsilateral or contralateral leg, which can be configured as reversed (valves disrupted and oriented away from flow) or in-situ (valves lysed endoscopically or with valvulotomes to preserve natural orientation). If suitable vein is unavailable due to prior harvest, varicose changes, or small caliber, prosthetic materials such as expanded (PTFE) or Dacron are used, particularly for above-knee or aortoiliac reconstructions where risk is lower. Vein harvest is performed concurrently or sequentially via longitudinal or endoscopic methods to minimize incisions and optimize conduit quality. The proximal anastomosis is typically end-to-side to the common , while the distal connects end-to-side to the above or below the , or to tibial vessels for infrapopliteal disease; may be performed at the anastomosis site to remove plaque and ensure a smooth lumen if heavy or is present. General vascular techniques, such as continuous monofilament sutures (5-0 or 6-0 ), are employed to achieve and patency. Graft tunneling occurs subcutaneously or subfascially to avoid compression and promote durability. Variations adapt to disease extent: aortobifemoral addresses bilateral iliac occlusive by anastomosing a bifurcated prosthetic graft from the distal to both femoral arteries, often via retroperitoneal or transperitoneal access. For distal occlusions below the knee, the graft targets the posterior tibial, anterior tibial, or peroneal arteries to maximize runoff and limb salvage. Alternative extra-anatomic routes, like axillary-femoral , may be used in high-risk patients unfit for abdominal exposure. Intraoperatively, systemic heparinization (70-100 units/kg, targeting activated clotting time of 250-300 seconds) prevents during clamping, with reversal using if needed. On-table or duplex assesses inflow, graft patency, and runoff immediately post-anastomosis to detect technical errors like kinks or stenoses. The procedure typically lasts 2-5 hours, depending on graft length and complexity; local or regional (e.g., spinal or epidural) is feasible for short-segment infrainguinal bypasses in select patients, while general is standard for longer or aortic reconstructions.

Risks and Complications

Peripheral surgery carries inherent risks, with rates typically ranging from 2% to 5%, though this increases to approximately 10% in patients with critical limb ischemia due to factors such as comorbidities and disease severity. Early postoperative complications are common and can significantly impact recovery. Graft occurs in 5% to 10% of cases within the first year, with autogenous vein grafts demonstrating superior patency compared to prosthetic conduits, which exhibit higher failure rates due to thrombogenicity. Wound infections affect 3% to 5% of patients, particularly those involving prosthetic grafts, where bacterial adherence is more pronounced. -related issues, including hematomas in up to 10% of cases, dehiscence in about 5%, and lymphatic leaks especially in incisions, further contribute to morbidity and may necessitate additional interventions. Distal , occurring in roughly 2% of procedures, arises from dislodged atherothrombotic debris during revascularization. Additionally, post-revascularization can develop due to , leading to elevated intracompartmental pressures and potential need for . Long-term complications primarily stem from biological responses and disease progression. Intimal hyperplasia, a proliferative response in the graft intima, contributes to occlusion rates of approximately 20% at 5 years, reducing patency and necessitating reintervention. Progression of native atherosclerotic disease in the peripheral arteries further exacerbates graft failure over time, independent of the conduit type. To mitigate these risks, lifelong antiplatelet therapy with aspirin is standard to prevent , while dual antiplatelet agents may be used initially for synthetic grafts. Regular surveillance with duplex every 3 to 6 months, combined with clinical assessment and ankle-brachial index measurements, enables early detection of or occlusion. General postoperative care emphasizes wound monitoring and mobility to reduce complication incidence.

Outcomes and Recovery

Peripheral vascular bypass surgery aims to restore blood flow, relieve ischemic symptoms, promote , and achieve limb salvage in patients with advanced (PAD). Primary patency rates (graft open without intervention) typically range from 60% to 80% at 1 year and 60% to 85% at 5 years for autogenous grafts, with secondary patency (after interventions) higher at 80-90%. Limb salvage rates, the key measure of success in critical limb ischemia, are approximately 80% to 90% at 1-3 years, though outcomes vary by patient factors like and tissue loss severity. Symptom relief, including reduced and rest pain, occurs in 70-80% of patients, with improved walking distance and when combined with modification. Long-term benefits are seen in select patients, with reduced amputation-related mortality, though overall 5-year survival is around 50-70% influenced by comorbidities. Recovery begins in , with a typical stay of 2-5 days for monitoring graft function, , and . Patients are encouraged to mobilize early (within 24-48 hours) to prevent and , starting with assisted walking and progressing to independence. involves analgesics, and wounds are monitored for . Discharge planning includes instructions on incision care, signs of complications (e.g., swelling, fever), and medications like antiplatelets (aspirin lifelong) and statins for control. Full recovery takes 6-8 weeks, during which patients gradually resume activities: light walking within days, return to work or driving in 2-4 weeks if non-strenuous, and full exercise by 6-8 weeks, avoiding heavy lifting initially. Cardiac or vascular rehabilitation programs, involving supervised exercise, , and , improve outcomes and reduce reintervention rates. Long-term follow-up includes duplex surveillance every 3-6 months for the first year, then annually, to detect graft early. Adherence to lifestyle changes, such as supervised exercise and lipid control, enhances patency and prevents disease progression. In cases of graft failure or recurrent ischemia, affecting 20-30% over 5 years, reintervention or alternative therapies may be needed.

References

  1. https://www.apollo247.com/health-topics/coronary-artery-disease/understanding-bypass-surgery
  2. https://www.mayoclinic.org/tests-procedures/coronary-bypass-surgery/about/pac-20384589
  3. https://www.nhlbi.nih.gov/health/coronary-artery-bypass-grafting
  4. https://www.ncbi.nlm.nih.gov/books/NBK507836/
  5. https://www.annalsthoracicsurgery.org/article/S0003-4975(25)00221-8/fulltext
  6. https://my.clevelandclinic.org/health/treatments/17611-venous-disease-bypass-surgery
  7. https://medlineplus.gov/ency/article/007199.htm
  8. https://my.clevelandclinic.org/health/treatments/17157-gastric-bypass-surgery
  9. https://my.clevelandclinic.org/health/treatments/16897-coronary-artery-bypass-surgery
  10. https://my.clevelandclinic.org/health/diseases/15796-biliary-stricture
  11. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/expert-answers/coronary-artery-disease/faq-20058302
  12. https://jamanetwork.com/journals/jamasurgery/fullarticle/508657
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC8869402/
  14. https://www.sciencedirect.com/science/article/pii/S2405857216300328
  15. https://www.americanjournalofsurgery.com/article/0002-9610%2881%2990187-2/pdf
  16. https://www.annalsofvascularsurgery.com/article/S0890-5096%2824%2900139-0/fulltext
  17. https://pubmed.ncbi.nlm.nih.gov/21658892/
  18. https://www.annalsthoracicsurgery.org/article/S0003-4975%2897%2900928-4/fulltext
  19. https://pubmed.ncbi.nlm.nih.gov/7052001/
  20. https://www.jtcvs.org/article/S0022-5223%2818%2930710-4/fulltext
  21. https://www.ncbi.nlm.nih.gov/books/NBK553157/
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC6806981/
  23. https://jtd.amegroups.org/article/view/19986/html
  24. https://www.ahajournals.org/doi/10.1161/circulationaha.110.985267
  25. https://www.jacc.org/doi/10.1016/j.jacbts.2025.101379
  26. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001285
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC7236882/
  28. https://asmedigitalcollection.asme.org/biomechanical/article/140/2/020804/367381/Biomechanics-and-Mechanobiology-of-Saphenous-Vein
  29. https://www.ahajournals.org/doi/10.1161/01.cir.0000141256.05740.69
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC2645354/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC3741887/
  32. https://www.ncbi.nlm.nih.gov/books/NBK534281/
  33. https://www.researchgate.net/figure/Conventional-end-toside-anastomosis-Using-a-7-0-or-8-0-polypropylene-suture-the_fig1_46698158
  34. https://pdfs.semanticscholar.org/68c5/b753b84a689464f55b464704f7e3e43011f4.pdf
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC3329286/
  36. https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/9781118768341.ch7
  37. https://vascular.org/sites/files/2022-01/SVS_Guideline_Follow-up_Overview.pdf
  38. https://asmbs.org/resources/informed-consent/
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC5536205/
  40. https://www.mayoclinic.org/tests-procedures/gastric-bypass-surgery/about/pac-20385189
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC9834364/
  42. https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/side-effects
  43. https://www.ncbi.nlm.nih.gov/books/NBK519489/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC1421184/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC11381104/
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC1360104/
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC7052530/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC6382659/
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC10013161/
  50. https://pubmed.ncbi.nlm.nih.gov/29204779/
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC4498416/
  52. https://www.mayoclinic.org/tests-procedures/gastric-bypass-surgery/in-depth/gastric-bypass-diet/art-20048472
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC8456424/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC5347111/
  55. https://pubmed.ncbi.nlm.nih.gov/22215166/
  56. https://pubmed.ncbi.nlm.nih.gov/21533520/
  57. https://www.jvascsurg.org/article/S0741-5214(19)30321-0/fulltext
  58. https://www.ncbi.nlm.nih.gov/books/NBK499827/
  59. https://diabetesjournals.org/care/article/39/11/2058/37216/Diabetes-Is-Associated-With-Decreased-Limb
  60. https://www.sciencedirect.com/science/article/pii/S0741521405004623
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC2868350/
  62. https://www.jvascsurg.org/article/S0741-5214%2822%2900412-8/fulltext
  63. https://www.mdpi.com/2076-3271/13/2/71
  64. https://www.ahajournals.org/doi/10.1161/circulationaha.111.059048
  65. https://evtoday.com/articles/2014-may/distal-embolization-during-percutaneous-lower-limb-interventions
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC5835435/
  67. https://research.rug.nl/files/14522826/c1.pdf
  68. https://my.clevelandclinic.org/health/treatments/24461-peripheral-artery-bypass
  69. https://www.jvascsurg.org/article/S0741-5214(24)01822-6/abstract
  70. https://pubmed.ncbi.nlm.nih.gov/39365192/
  71. https://medlineplus.gov/ency/patientinstructions/000239.htm
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC8012193/
Add your contribution
Related Hubs
User Avatar
No comments yet.